Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial

10.1002/clc.22507

Saved in:

Bibliographic Details
Main Authors:	Chung, R, Maulik, A, Hamarneh, A, Hochhauser, D, Hausenloy, D.J, Walker, J.M, Yellon, D.M
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	John Wiley and Sons Inc. 2020
Subjects:	amino terminal pro brain natriuretic peptide anthracycline antineoplastic agent microRNA mitochondrial DNA troponin T antineoplastic antibiotic adult aged arm Article blood pressure cuff cancer chemotherapy cancer patient cardiotoxicity cardiovascular disease controlled study echography female follow up heart arrhythmia heart injury heart protection heart ventricle function human major clinical study male malignant neoplastic disease multiple cycle treatment outcome assessment protein blood level proteomics randomized controlled trial remote ischemic conditioning single blind procedure study design treatment response blood flow chemically induced clinical protocol England Heart Diseases ischemic preconditioning methodology Neoplasms procedures time factor treatment outcome upper limb vascularization Anthracyclines Antibiotics, Antineoplastic Cardiotoxicity Clinical Protocols Humans Ischemic Preconditioning London Regional Blood Flow Research Design Single-Blind Method Time Factors Treatment Outcome Upper Extremity
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/179599
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-179599
record_format	dspace
spelling	sg-nus-scholar.10635-1795992023-09-21T08:31:29Z Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial Chung, R Maulik, A Hamarneh, A Hochhauser, D Hausenloy, D.J Walker, J.M Yellon, D.M DUKE-NUS MEDICAL SCHOOL amino terminal pro brain natriuretic peptide anthracycline antineoplastic agent microRNA mitochondrial DNA troponin T anthracycline antineoplastic antibiotic adult aged arm Article blood pressure cuff cancer chemotherapy cancer patient cardiotoxicity cardiovascular disease controlled study echography female follow up heart arrhythmia heart injury heart protection heart ventricle function human major clinical study male malignant neoplastic disease multiple cycle treatment outcome assessment protein blood level proteomics randomized controlled trial remote ischemic conditioning single blind procedure study design treatment response blood flow cardiotoxicity chemically induced clinical protocol England Heart Diseases ischemic preconditioning methodology Neoplasms procedures time factor treatment outcome upper limb vascularization Anthracyclines Antibiotics, Antineoplastic Cardiotoxicity Clinical Protocols Heart Diseases Humans Ischemic Preconditioning London Neoplasms Regional Blood Flow Research Design Single-Blind Method Time Factors Treatment Outcome Upper Extremity 10.1002/clc.22507 Clinical Cardiology 39 2 72-82 2020-10-23T07:59:36Z 2020-10-23T07:59:36Z 2016 Article Chung, R, Maulik, A, Hamarneh, A, Hochhauser, D, Hausenloy, D.J, Walker, J.M, Yellon, D.M (2016). Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial. Clinical Cardiology 39 (2) : 72-82. ScholarBank@NUS Repository. https://doi.org/10.1002/clc.22507 0160-9289 https://scholarbank.nus.edu.sg/handle/10635/179599 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ John Wiley and Sons Inc. Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	amino terminal pro brain natriuretic peptide anthracycline antineoplastic agent microRNA mitochondrial DNA troponin T anthracycline antineoplastic antibiotic adult aged arm Article blood pressure cuff cancer chemotherapy cancer patient cardiotoxicity cardiovascular disease controlled study echography female follow up heart arrhythmia heart injury heart protection heart ventricle function human major clinical study male malignant neoplastic disease multiple cycle treatment outcome assessment protein blood level proteomics randomized controlled trial remote ischemic conditioning single blind procedure study design treatment response blood flow cardiotoxicity chemically induced clinical protocol England Heart Diseases ischemic preconditioning methodology Neoplasms procedures time factor treatment outcome upper limb vascularization Anthracyclines Antibiotics, Antineoplastic Cardiotoxicity Clinical Protocols Heart Diseases Humans Ischemic Preconditioning London Neoplasms Regional Blood Flow Research Design Single-Blind Method Time Factors Treatment Outcome Upper Extremity
spellingShingle	amino terminal pro brain natriuretic peptide anthracycline antineoplastic agent microRNA mitochondrial DNA troponin T anthracycline antineoplastic antibiotic adult aged arm Article blood pressure cuff cancer chemotherapy cancer patient cardiotoxicity cardiovascular disease controlled study echography female follow up heart arrhythmia heart injury heart protection heart ventricle function human major clinical study male malignant neoplastic disease multiple cycle treatment outcome assessment protein blood level proteomics randomized controlled trial remote ischemic conditioning single blind procedure study design treatment response blood flow cardiotoxicity chemically induced clinical protocol England Heart Diseases ischemic preconditioning methodology Neoplasms procedures time factor treatment outcome upper limb vascularization Anthracyclines Antibiotics, Antineoplastic Cardiotoxicity Clinical Protocols Heart Diseases Humans Ischemic Preconditioning London Neoplasms Regional Blood Flow Research Design Single-Blind Method Time Factors Treatment Outcome Upper Extremity Chung, R Maulik, A Hamarneh, A Hochhauser, D Hausenloy, D.J Walker, J.M Yellon, D.M Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
description	10.1002/clc.22507
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Chung, R Maulik, A Hamarneh, A Hochhauser, D Hausenloy, D.J Walker, J.M Yellon, D.M
format	Article
author	Chung, R Maulik, A Hamarneh, A Hochhauser, D Hausenloy, D.J Walker, J.M Yellon, D.M
author_sort	Chung, R
title	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
title_short	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
title_full	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
title_fullStr	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
title_full_unstemmed	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
title_sort	effect of remote ischaemic conditioning in oncology patients undergoing chemotherapy: rationale and design of the eric-onc study - a single-center, blinded, randomized controlled trial
publisher	John Wiley and Sons Inc.
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/179599
_version_	1779152514538536960

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial

Similar Items